Haverford Trust Company’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $324K | Sell |
1,107
-3
| -0.3% | -$986 | ﹤0.01% | 353 |
|
|
2025
Q4 | $389K | Buy |
1,110
+3
| +0.3% | +$1.01K | ﹤0.01% | 328 |
|
|
2025
Q3 | $358K | Sell |
1,107
-2,008
| -64% | -$625K | ﹤0.01% | 326 |
|
|
2025
Q2 | $1.21M | Hold |
3,115
| – | – | 0.01% | 215 |
|
|
2025
Q1 | $1.35M | Sell |
3,115
-153
| -5% | -$61.4K | 0.01% | 202 |
|
|
2024
Q4 | $1.21M | Sell |
3,268
-22
| -0.7% | -$9.21K | 0.01% | 206 |
|
|
2024
Q3 | $1.71M | Buy |
3,290
+13
| +0.4% | +$6.95K | 0.02% | 185 |
|
|
2024
Q2 | $1.78M | Sell |
3,277
-95
| -3% | -$50.2K | 0.02% | 182 |
|
|
2024
Q1 | $1.75M | Sell |
3,372
-22
| -0.6% | -$10.9K | 0.02% | 182 |
|
|
2023
Q4 | $1.6M | Buy |
3,394
+35
| +1% | +$16.2K | 0.02% | 178 |
|
|
2023
Q3 | $1.46M | Hold |
3,359
| – | – | 0.02% | 175 |
|
|
2023
Q2 | $1.49M | Sell |
3,359
-39
| -1% | -$18K | 0.02% | 175 |
|
|
2023
Q1 | $1.56M | Buy |
3,398
+190
| +6% | +$90.4K | 0.02% | 162 |
|
|
2022
Q4 | $1.65M | Sell |
3,208
-470
| -13% | -$239K | 0.02% | 154 |
|
|
2022
Q3 | $1.67M | Sell |
3,678
-98
| -3% | -$46.9K | 0.02% | 149 |
|
|
2022
Q2 | $1.82M | Buy |
3,776
+150
| +4% | +$74.2K | 0.02% | 152 |
|
|
2022
Q1 | $1.78M | Sell |
3,626
-120
| -3% | -$54.9K | 0.02% | 155 |
|
|
2021
Q4 | $1.74M | Sell |
3,746
-625
| -14% | -$263K | 0.02% | 160 |
|
|
2021
Q3 | $1.63M | Sell |
4,371
-91
| -2% | -$34.6K | 0.02% | 161 |
|
|
2021
Q2 | $1.7M | Buy |
4,462
+297
| +7% | +$114K | 0.02% | 162 |
|
|
2021
Q1 | $1.5M | Hold |
4,165
| – | – | 0.02% | 157 |
|
|
2020
Q4 | $1.34M | Buy |
4,165
+395
| +10% | +$121K | 0.02% | 145 |
|
|
2020
Q3 | $1.01M | Hold |
3,770
| – | – | 0.02% | 160 |
|
|
2020
Q2 | $991K | Sell |
3,770
-2
| -0.1% | -$534 | 0.02% | 155 |
|
|
2020
Q1 | $856K | Sell |
3,772
-60
| -2% | -$16.4K | 0.02% | 158 |
|
|
2019
Q4 | $1.16M | Buy |
3,832
+2,069
| +117% | +$569K | 0.02% | 161 |
|
|
2019
Q3 | $423K | Buy |
1,763
+33
| +2% | +$9.04K | 0.01% | 223 |
|
|
2019
Q2 | $488K | Buy |
1,730
+101
| +6% | +$27.6K | 0.01% | 211 |
|
|
2019
Q1 | $467K | Sell |
1,629
-175
| -10% | -$50.6K | 0.01% | 213 |
|
|
2018
Q4 | $474K | Sell |
1,804
-285
| -14% | -$78.4K | 0.01% | 206 |
|
|
2018
Q3 | $572K | Hold |
2,089
| – | – | 0.01% | 197 |
|
|
2018
Q2 | $497K | Sell |
2,089
-151
| -7% | -$35K | 0.01% | 207 |
|
|
2018
Q1 | $492K | Buy |
2,240
+515
| +30% | +$121K | 0.01% | 202 |
|
|
2017
Q4 | $388K | Buy |
1,725
+615
| +55% | +$131K | 0.01% | 215 |
|
|
2017
Q3 | $211K | Hold |
1,110
| – | – | ﹤0.01% | 260 |
|
|
2017
Q2 | $209K | Buy |
+1,110
| New | +$199K | ﹤0.01% | 250 |
|
Other funds holding ELV
VCM
VPM
Haverford Trust Company's ELV Position: Q1 2026 in Review
Haverford Trust Company reduced its Elevance Health (ELV) stake by 0.27% in Q1 2026, selling an estimated $986 and leaving 1,107 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #353.
Haverford Trust Company first reported a position in ELV in Q2 2017 and has held it in 36 quarters since. The position peaked at $1.82M in Q2 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Haverford Trust Company held 1,107 shares of Elevance Health worth $324K as of Q1 2026.
- Haverford Trust Company sold 3 Elevance Health shares in Q1 2026, an estimated $986.
- Elevance Health made up ﹤0.01% of Haverford Trust Company's portfolio in Q1 2026, its #353 holding.
- Haverford Trust Company first reported a position in Elevance Health in Q2 2017 and has held it in 36 quarters since.
- Haverford Trust Company's Elevance Health position peaked at $1.82M in Q2 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Haverford Trust Company's 13F filing for Q1 2026, filed 11 May 2026.